Productive Policy Depends On Public's Understanding Of Scientific Issues

Understanding Of Scientific Issues In our democratic society, in which scientific and technological controversies crowd the public agenda, the American people often are asked to make judgments about unfamiliar, complex issues. On many such issues, the scientific community cannot detail with certainty the likely outcome of many trends or policies. When experts disagree, how can the public acquire enough knowledge to participate thoughtfully in developing policy responses to such controversies? A

Written byJohn Doble
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Understanding Of Scientific Issues In our democratic society, in which scientific and technological controversies crowd the public agenda, the American people often are asked to make judgments about unfamiliar, complex issues. On many such issues, the scientific community cannot detail with certainty the likely outcome of many trends or policies. When experts disagree, how can the public acquire enough knowledge to participate thoughtfully in developing policy responses to such controversies? And if the public is not involved, what are the implications for society?

The issue is often debated in the scholarly community. Some maintain that reasonable involvement by a public that is, on the whole, woefully lacking in scientific literacy is impossible. Jon Miller, a professor of political science at Northern Illinois University, argues that only the roughly 20 percent of the public who are comparatively well-informed about science-the "scientifically literate"-have the requisite background, understanding, and level of interest to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies